Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sheng-Ke Tu

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
World Journal of Clinical Oncology|January 27, 2025
Extramedullary plasmacytoma with the uvula as first affected site: A case reportJing Yang, Hui Peng, Sheng-Ke Tu, et al.
Medicine|April 21, 2025
Two cases of Kallmann syndrome caused by a novel mutation in ANOS1: A case reportJin-Ke Xiong, Sheng-Ke Tu, Min Shi, et al.
Oncology Letters|December 19, 2025
Primary bone marrow diffuse large B-cell lymphoma with secondary myelofibrosis: A case reportJing Yang, Sheng-Ke Tu, Hui Peng, et al.
World Journal of Clinical Cases|November 10, 2023
First platelet transfusion refractoriness in a patient with acute myelocytic leukemia: A case reportSheng-Ke Tu, Hong-Jie Fan, Zi-Wei Shi, et al.
Frontiers in Oncology|January 19, 2026
Construction and validation of a simple, scoreable model for predicting infection risk in patients with multiple myeloma: a retrospective single-center studySheng-Ke Tu, Jing Yang, Sha-Dong Min, et al.
Experimental and Therapeutic Medicine|September 20, 2024
Imatinib‑induced gynecomastia: A case reportXiao-Lan Li, Min Li, Sheng-Ke Tu, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
World Journal of Clinical Oncology|January 27, 2025
Extramedullary plasmacytoma with the uvula as first affected site: A case reportJing Yang, Hui Peng, Sheng-Ke Tu, et al.
Medicine|April 21, 2025
Two cases of Kallmann syndrome caused by a novel mutation in ANOS1: A case reportJin-Ke Xiong, Sheng-Ke Tu, Min Shi, et al.
Oncology Letters|December 19, 2025
Primary bone marrow diffuse large B-cell lymphoma with secondary myelofibrosis: A case reportJing Yang, Sheng-Ke Tu, Hui Peng, et al.
World Journal of Clinical Cases|November 10, 2023
First platelet transfusion refractoriness in a patient with acute myelocytic leukemia: A case reportSheng-Ke Tu, Hong-Jie Fan, Zi-Wei Shi, et al.
Frontiers in Oncology|January 19, 2026
Construction and validation of a simple, scoreable model for predicting infection risk in patients with multiple myeloma: a retrospective single-center studySheng-Ke Tu, Jing Yang, Sha-Dong Min, et al.
Experimental and Therapeutic Medicine|September 20, 2024
Imatinib‑induced gynecomastia: A case reportXiao-Lan Li, Min Li, Sheng-Ke Tu, et al.
Pageof 1